CSL Ltd
ASX:CSL
CSL Ltd
EPS (Diluted)
CSL Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CSL Ltd
ASX:CSL
|
EPS (Diluted)
$5
|
CAGR 3-Years
-4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
Immutep Ltd
ASX:IMM
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Opthea Ltd
ASX:OPT
|
EPS (Diluted)
$0
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-18%
|
|
Mesoblast Ltd
ASX:MSB
|
EPS (Diluted)
$0
|
CAGR 3-Years
21%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
10%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
EPS (Diluted)
AU$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is CSL Ltd's EPS (Diluted)?
EPS (Diluted)
5.1
USD
Based on the financial report for Dec 31, 2023, CSL Ltd's EPS (Diluted) amounts to 5.1 USD.
What is CSL Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
7%
Over the last year, the EPS (Diluted) growth was 16%. The average annual EPS (Diluted) growth rates for CSL Ltd have been -4% over the past three years , 5% over the past five years , and 7% over the past ten years .